NAT10 and hepatocellular carcinoma: WB results showed that silencing NAT10 upregulated E‐cadherin (CDH1) expression and downregulated vimentin (VIM) expression, suggesting that NAT10 influences the EMT process in HCC cells (Figure 2D).